
Please try another search
Investors in the North American cannabis market have to search for the positive signs. Are there any indicators of a turnaround? Anywhere? Somewhere?
One glimmer of positivity is sales growth.
So, let’s take a look at one marijuana stock that has registered the highest year-over-year growth in sales: OrganiGram Holdings (NASDAQ:OGI) (TSX:OGI).
This Canadian-based marijuana grower, founded in 2013, had a 118% increase in sales growth, according to its latest earnings report, making it the leader in this category among pot stocks trading on the NASDAQ.
Shares of the company, however, have not fared as well. The stock closed yesterday at US$1.080 in New York, down more than 5.5% on the day, and C$1.35 in Toronto, down about 3.5%. Year-to-date in 2022, the stock is down about 40%, and just over 63.5% in the last year.
Source: Investing.com
Rising sales figures are one measure of a grower's ability to increase revenue organically. But how improved sales figures are contributing to profitability is a key metric to watch as well.
The company’s net income has improved, but it has yet to reach profitability. Its net revenue last quarter stood at C$4.05 million (USD$3.6M).
In OrganiGram’s case, one of the contributors to its increased sales is a deal it struck in June 2020 that gave it access to the international market.
The marijuana grower, which began as a medical cannabis producer, today grows for both the medical and recreational markets. Two years ago, it inked a deal to supply dried cannabis flower to largest medical cannabis company in Israel.
The bad news keeps chipping away at Canopy Growth shares (NASDAQ:CGC) (TSX:WEED).
Earlier this week, the Canadian-based cannabis grower was one of only two stocks on the S&P/TSX Composite to hit a 52-week low.
The marijuana company has lost 11.8% in the past week and almost 51% so far this year.
Yesterday, the stock closed at US$4.09 on NASDAQ, down 5.3% on the day, and C$5.13 on the TSX Composite, down 5.35% on the day.
The stock has now lost more than 82% in the last 12 months.
Here is a quick stat for you, from the land of legalized pot.
A total of C$10.54 billion was generated in cannabis sales in the first quarter of 2022 on an annualized basis, according to Statistics Canada.
The figure represents a 7.9% increase compared with the previous year, the data shows.
There have been so many Home Construction site fires in Southern Ontario this year, way to may than normal, what the heck is going on? Some were clearly Arson, what about the...
This week will be the capstone of 2023 because whatever happens this week will be a send-off message as 2024 approaches. This week will feature CPI, PPI, and retail sales on the...
US futures are pointing to a flat open as of 04:50 ET. European equity markets are slightly higher after a mixed and choppy session in Asia. China markets sold off first thing on...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.